sponsored
PatientsVille.com Logo

PatientsVille

Cephalexin and Concerta

Compare Side Effects

% of total side effects reported by users. DISCLAIMER: ALL DATA PROVIDED AS-IS. Data Source: openfda.gov.
Side EffectCephalexinConcerta
DRUG INEFFECTIVE1.4% 5.3%
PAIN3.3% 1.1%
HEADACHE1.8% 2.9%
NAUSEA2.8% 2.4%
FATIGUE2.5% 2.2%
DIARRHOEA2.4% 0.8%
ANXIETY2.3% 2.3%
DEPRESSION1.7% 2.3%
DYSPNOEA2.3% 1%
INSOMNIA1% 2.3%
AGGRESSION0% 2.1%
OFF LABEL USE0% 2%
SUICIDAL IDEATION0% 2%
DIZZINESS1.9% 1.6%
DRUG DOSE OMISSION0.5% 1.9%
CHRONIC KIDNEY DISEASE1.9% 0%
VOMITING1.8% 1.7%
DECREASED APPETITE0.8% 1.8%
ABNORMAL BEHAVIOUR0% 1.8%
RENAL FAILURE1.8% 0%
RASH1.7% 0.8%
FALL1.7% 0.6%
DISTURBANCE IN ATTENTION0% 1.7%
INJURY1.7% 0%
WEIGHT DECREASED1.1% 1.6%
ASTHENIA1.6% 0.7%
FEELING ABNORMAL0.6% 1.6%
SOMNOLENCE0.6% 1.5%
WEIGHT INCREASED0.6% 1.5%
PAIN IN EXTREMITY1.5% 0.5%
ARTHRALGIA1.5% 0.5%
DRUG HYPERSENSITIVITY1.5% 0%
URINARY TRACT INFECTION1.5% 0%
AGITATION0% 1.5%
HYPERTENSION1.4% 1.2%
PYREXIA1.4% 0.8%
ACUTE KIDNEY INJURY1.4% 0%
CHEST PAIN1.3% 0.9%
BACK PAIN1.3% 0.5%
DEEP VEIN THROMBOSIS1.3% 0%
PRODUCT SUBSTITUTION ISSUE0% 1.3%
ABDOMINAL PAIN1.2% 0.8%
PRURITUS1.2% 0.7%
PNEUMONIA1.2% 0%
TACHYCARDIA0% 1.2%
IRRITABILITY0% 1.2%
SUICIDE ATTEMPT0% 1.2%
MALAISE1.1% 1.1%
TREMOR0.6% 1.1%
OEDEMA PERIPHERAL1.1% 0%
ANAEMIA1.1% 0%
COUGH1% 0.5%
CONSTIPATION1% 0.4%
PRODUCT USE ISSUE0% 1%
MYOCARDIAL INFARCTION1% 0%
DRUG EFFECT DECREASED0% 1%
EMOTIONAL DISTRESS1% 0%
PULMONARY EMBOLISM1% 0%
OVERDOSE0% 1%
HALLUCINATION0% 1%
ABDOMINAL PAIN UPPER0.9% 0.8%
CONDITION AGGRAVATED0.6% 0.9%
PALPITATIONS0.6% 0.9%
DRUG INTERACTION0.5% 0.9%
HYPOAESTHESIA0.9% 0.5%
DEHYDRATION0.9% 0%
PSYCHOTIC DISORDER0% 0.9%
HEART RATE INCREASED0% 0.9%
TIC0% 0.9%
DEATH0.9% 0%
HYPOTENSION0.9% 0%
CELLULITIS0.9% 0%
CEREBROVASCULAR ACCIDENT0.9% 0%
CONFUSIONAL STATE0.8% 0.7%
MUSCLE SPASMS0.8% 0.5%
TOXICITY TO VARIOUS AGENTS0% 0.8%
GASTROOESOPHAGEAL REFLUX DISEASE0.8% 0%
CARDIAC FAILURE CONGESTIVE0.8% 0%
ANGER0% 0.8%
PSYCHOMOTOR HYPERACTIVITY0% 0.8%
GYNAECOMASTIA0% 0.8%
ECONOMIC PROBLEM0.8% 0%
HYPERHIDROSIS0.5% 0.7%
PARAESTHESIA0.7% 0.5%
HOSPITALISATION0% 0.7%
GAIT DISTURBANCE0.7% 0%
ERYTHEMA0.7% 0%
GROWTH RETARDATION0% 0.7%
URTICARIA0.7% 0%
ADVERSE EVENT0% 0.7%
BRONCHITIS0.7% 0%
BLOOD PRESSURE INCREASED0% 0.7%
SINUSITIS0.7% 0%
DYSKINESIA0% 0.7%
INCORRECT DOSE ADMINISTERED0% 0.7%
VISION BLURRED0.5% 0.6%
LOSS OF CONSCIOUSNESS0.5% 0.6%
SYNCOPE0.5% 0.6%
RESTLESSNESS0% 0.6%
CONVULSION0% 0.6%
DRUG ABUSE0% 0.6%
MOOD SWINGS0% 0.6%
PRODUCT QUALITY ISSUE0% 0.6%
TREATMENT NONCOMPLIANCE0% 0.6%
CRYING0% 0.6%
INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION0% 0.6%
SLEEP DISORDER0% 0.6%
OSTEOARTHRITIS0.6% 0%
INFECTION0.6% 0%
CONTUSION0.6% 0%
CORONARY ARTERY DISEASE0.6% 0%
ANHEDONIA0.6% 0%
NEUROPATHY PERIPHERAL0.6% 0%
DYSPHAGIA0.6% 0%
MYALGIA0.6% 0%
CHOLELITHIASIS0.6% 0%
DIABETES MELLITUS0.6% 0%
ATRIAL FIBRILLATION0.6% 0%
HYPERSENSITIVITY0.5% 0.4%
MIGRAINE0% 0.5%
DEPRESSED MOOD0% 0.5%
ATTENTION DEFICIT/HYPERACTIVITY DISORDER0% 0.5%
COMPLETED SUICIDE0% 0.5%
INTENTIONAL OVERDOSE0% 0.5%
EMOTIONAL DISORDER0% 0.5%
MEMORY IMPAIRMENT0% 0.5%
CHOLECYSTITIS CHRONIC0.5% 0%
WRONG TECHNIQUE IN PRODUCT USAGE PROCESS0% 0.5%
HALLUCINATION, AUDITORY0% 0.5%
HALLUCINATION, VISUAL0% 0.5%
ALOPECIA0.5% 0%
SEPSIS0.5% 0%
CHEST DISCOMFORT0.5% 0%
PERIPHERAL SWELLING0.5% 0%
GENERAL PHYSICAL HEALTH DETERIORATION0.5% 0%
CHRONIC OBSTRUCTIVE PULMONARY DISEASE0.5% 0%
HAEMOGLOBIN DECREASED0.5% 0%
CHILLS0.5% 0%
OSTEOPOROSIS0.5% 0%
ABDOMINAL DISCOMFORT0.5% 0%
ARTHRITIS0.5% 0%
SWELLING0.5% 0%
MUSCULAR WEAKNESS0.5% 0%
END STAGE RENAL DISEASE0.5% 0%
RENAL FAILURE ACUTE0.5% 0%
DYSPEPSIA0.5% 0%
NASOPHARYNGITIS0% 0.4%
DYSTONIA0% 0.4%
PRODUCT USE IN UNAPPROVED INDICATION0% 0.4%
UNEVALUABLE EVENT0% 0.4%
DRY MOUTH0% 0.4%
NERVOUSNESS0% 0.4%
SPEECH DISORDER0% 0.4%
MOOD ALTERED0% 0.4%

New treatments are found every day. View current Cephalexin research studies and Concerta clinical trials

1